Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the Verigene Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay
Authors:
Open Access
- 1 August 2015
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 53 (8) , 2460-2472
Abstract
Bloodstream infection is a serious condition associated with significant morbidity and mortality. The outcome of these infections can be positively affected by the early implementation of effective antibiotic therapy based on the identification of the infecting organism and genetic markers associated with antibiotic resistance. In this study, we evaluated the microarray-based Verigene Gram-negative blood culture (BC-GN) assay in the identification of 8 genus or species targets and 6 genetic resistance determinants in positive blood culture broths. A total of 1,847 blood cultures containing Gram-negative organisms were tested using the BC-GN assay. This comprised 729 prospective fresh, 781 prospective or retrospective frozen, and 337 simulated cultures representing 7 types of aerobic culture media. The results were compared to those with standard bacterial culture and biochemical identification with nucleic acid sequence confirmation of the resistance determinants. Among monomicrobial cultures, the positive percent agreement (PPA) of the BC-GN assay with the reference method was as follows; Escherichia coli , 100%; Klebsiella pneumoniae , 92.9%; Klebsiella oxytoca , 95.5%; Enterobacter spp., 99.3%; Pseudomonas aeruginosa , 98.9%; Proteus spp., 100%; Acinetobacter spp., 98.4%; and Citrobacter spp., 100%. All organism identification targets demonstrated >99.5% negative percent agreement (NPA) with the reference method. Of note, 25/26 cultures containing K. pneumoniae that were reported as not detected by the BC-GN assay were subsequently identified as Klebsiella variicola . The PPA for identification of resistance determinants was as follows; bla CTX-M , 98.9%; bla KPC , 100%; bla NDM , 96.2%; bla OXA , 94.3%; bla VIM , 100%; and bla IMP , 100%. All resistance determinant targets demonstrated >99.9% NPA. Among polymicrobial specimens, the BC-GN assay correctly identified at least one organism in 95.4% of the broths and correctly identified all organisms present in 54.5% of the broths. The sample-to-result processing and automated reading of the detection microarray results enables results within 2 h of culture positivity.Keywords
This publication has 54 references indexed in Scilit:
- Evaluation of the Nanosphere Verigene BC-GN Assay for Direct Identification of Gram-Negative Bacilli and Antibiotic Resistance Markers from Positive Blood Cultures and Potential Impact for More-Rapid Antibiotic InterventionsJournal of Clinical Microbiology, 2014
- Potential Impact of a Microarray-Based Nucleic Acid Assay for Rapid Detection of Gram-Negative Bacteria and Resistance Markers in Positive Blood CulturesJournal of Clinical Microbiology, 2014
- Fatal sepsis caused by an unusual Klebsiella species that was misidentified by an automated identification systemJournal of Medical Microbiology, 2013
- Rapid Detection of Carbapenemase-Producing Pseudomonas sppJournal of Clinical Microbiology, 2012
- Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007Antimicrobial Agents and Chemotherapy, 2011
- AmpC β-LactamasesClinical Microbiology Reviews, 2009
- Use of Active Surveillance Cultures to Detect Asymptomatic Colonization With Carbapenem-Resistant Klebsiella pneumoniae in Intensive Care Unit PatientsInfection Control & Hospital Epidemiology, 2008
- The CTX-M β-lactamase pandemicCurrent Opinion in Microbiology, 2006
- Antibiotic Therapy for Klebsiella pneumoniae Bacteremia: Implications of Production of Extended-Spectrum -LactamasesClinical Infectious Diseases, 2004